The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Frontotemporal dementia (FTD) is a rare and progressive form of dementia that primarily affects people between the ages of 40 ...

The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

The Prescription Drug User Fee Act (PDUFA) action date has been set to August ... Lecanemab is approved in the U.S., Japan, China, and several other markets for the treatment of mild cognitive ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Dementia cases are expected to more than double in the coming decades, with the risk beginning as early as 55, and the ...

New research suggests that Americans' risk for developing dementia over a lifetime may be higher than previously thought.